Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GM-18 - A Randomized, Multicenter, Study for the prEvention and Acute Treatment of Migraine Using Open Label Non-invasive Vagal Nerve Stimulation, Versus Standard of Care (REAL)

NCT03787238 is registered in ClinicalTrials.gov with ElectroCore INC as lead sponsor.

NCT NCT03787238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03787238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GM-18 - A Randomized, Multicenter, Study for the prEvention and Acute Treatment of Migraine Using Open Label Non-invasive Vagal Nerve Stimulation, Versus Standard of Care (REAL)
Lead sponsor
ElectroCore INC
Phase
Not applicable
Overall status
Withdrawn
Start date
May 15, 2019
Completion date
October 1, 2020
Enrollment
0 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

migraine